High-SensitivityBRAFMutation Analysis:BRAFV600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas-Reference-Cited by-同舟云学术

High-SensitivityBRAFMutation Analysis:BRAFV600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas

Published:2014-08-01 Issue:8 Volume:99 Page:E1530-E1538
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

de Biase Dario¹,Cesari Valentina¹²,Visani Michela²,Casadei Gian Piero³,Cremonini Nadia⁴,Gandolfi Greta⁵,Sancisi Valentina⁵,Ragazzi Moira⁶,Pession Annalisa²,Ciarrocchi Alessia⁵,Tallini Giovanni¹

Affiliation:

1. Department of Medicine (D.d.B., V.C., G.T.), Anatomic Pathology Unit, Ospedale Bellaria, University of Bologna, 40139 Bologna, Italy

2. Department of Pharmacology and Biotechnology (V.C., M.V., A.P.), University of Bologna, 40100 Bologna, Italy

3. Anatomic Pathology Unit (G.P.C.), 40133 Bologna, Italy

4. Endocrinology Unit (N.C.), Ospedale Maggiore, 40133 Bologna, Italy

5. Molecular Biology Laboratory (G.G., V.S., A.C.), 42123 Reggio Emilia, Italy

6. Anatomic Pathology Unit (M.R.), Istituto di Ricovero e Cura a Carattere Scientifico-Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/99/8/E1530/9047205/jcem1530.pdf

Reference28 articles.

1. BRAF mutations in advanced cancers: clinical characteristics and outcomes;El-Osta;PloS One,2011

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

4. Thyroid cancer survival in the United States: observational data from 1973 to 2005;Davies;Arch Otolaryngol Head Neck Surg,2010

5. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma;Kimura;Cancer Res,2003

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of BRAF V600E Mutant Allele Proportion with the Dissemination Stage of Papillary Thyroid Cancer;Biomedicines;2024-02-21

2. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia;Molecular and Cellular Endocrinology;2024-02

3. Cigarette smoking and thyroid cancer risk: A Mendelian randomization study;Cancer Medicine;2023-09-25

4. Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre;International Journal of Molecular Sciences;2023-02-17

5. Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies;Journal of Translational Medicine;2023-01-09